Your browser doesn't support javascript.
loading
Protective effects of nigella sativa oil against gentamicin-induced ototoxicity in rats: A dose-ranging study.
Tuna, Bilge; Tüzemen, Gökhan.
Afiliación
  • Tuna B; Bursa City Hospital, Department of Otorhinolaryngology, Turkey. Electronic address: opdrbilgetuna@gmail.com.
  • Tüzemen G; Bursa City Hospital, Department of Otorhinolaryngology, Turkey. Electronic address: tuzemeng@yahoo.com.tr.
Int J Pediatr Otorhinolaryngol ; 164: 111405, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36481814
OBJECTIVE: Aminoglycosides are relatively potent antibiotics used against some life-threatening infections but contribute to ototoxicity. Although the beneficial effects of high-dose nigella sativa oil (NSO) on ototoxicity in the form of intratympanic or oral use have been demonstrated, no variable-dose studies have been conducted on this subject. We aimed to investigate the potential protective effect of different doses of intraperitoneal (i.p.) NSO on Gentamicin (GM)-induced ototoxicity with auditory brainstem responses (ABR) testing. METHODS: Thirty adult male Sprague-Dawley rats (300-400 gr) were used in this study. Rats were randomly divided into 5 groups, with six animals in each group: All the groups received GM (120 mg/kg i.p) for ten days. Group 1: 0.9% saline solution (0.3 ml/kg i.p.), Group 2: NSOL (low dose 0.1 ml/kg i.p.), Group 3: NSOM (median dose 0.3 ml/kg i.p.), Group 4: NSOH (high dose 3 ml/kg i.p.), Group 5: NSOML (late onset median dose 0.3 ml/kg i.p) were given for fifteen days. But death occurred in 3 rats in group 4 and they were excluded from the study. The pretreatment and posttreatment ABR testings were performed. RESULTS: The posttreatment ABR results were compared with the pretreatment values. A significant difference was found in group 1 (p:0,002), group 2 (p: 0,040), and group 4 (p: 0,027). When the posttreatment tests were compared with each other, there was a significant difference between groups 1 and 2 (p < 0,001), groups 1 and 3 (p < 0,001), and groups 1 and 5 (p < 0,001). CONCLUSIONS: The administration of 0.1 ml/kg and 3 ml/kg dose of NSO does not prevent ototoxicity. The 0.3 ml/kg dose of NSO effectively prevents GM-induced ototoxicity within both prophylactic and therapeutic use.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Gentamicinas / Ototoxicidad Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Int J Pediatr Otorhinolaryngol Año: 2023 Tipo del documento: Article Pais de publicación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Gentamicinas / Ototoxicidad Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Int J Pediatr Otorhinolaryngol Año: 2023 Tipo del documento: Article Pais de publicación: Irlanda